Taiwan recalls diabetes medication alleged to contain extra material

Focus Taiwan
Date: 12/17/2020
By: Chang Ming-hsuan and Chung Yu-chen

Taipei, Dec. 17 (CNA) A total of 1 million diabetes drugs manufactured by Taiwan's pharmaceutical company Standard Chem. & Pharm. CO., LTD are being recalled because they are alleged to contain extraneous

Photo courtesy of Food and Drug Administration

material, according to the Taiwan Food and Drug Administration (FDA) on Thursday.

The recall involves two types of drugs, Metformin 500 (batch number: TL092117) and Metformin 850 (batch number: TL180260), which were alleged to contain extraneous material made of fiber, the administration said.

Metformin 500 and Metformin 850, which together comprise a 20 percent market share for this type of drug, are frequently used by diabetic patients, said Hung Kuo-teng (洪國登), head of the FDA's Medicinal Products Division, at a telephone interview with reporters on Thursday.

As to what exactly the drugs were found to contain, Hung said the Tainan City-based company is now looking into the case and is required to submit an investigative report at the end of this December.    [FULL  STORY]

Leave a Reply

Your email address will not be published. Required fields are marked *

I accept the Privacy Policy

This site uses Akismet to reduce spam. Learn how your comment data is processed.